Editor-in-Chief, Dr Lan-Lan Smith, speaks with Dr Judith Boer (Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands) about outcome of ABL-class acute lymphoblastic leukaemia in children in the pre-tyrosine kinase inhibitor era.

Read the full article:
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(20)30353-7/fulltext